UBS AM’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.62M | Buy |
288,736
+115,723
| +67% | +$1.85M | ﹤0.01% | 1750 |
|
|
2025
Q1 | $3.36M | Buy |
173,013
+24,881
| +17% | +$483K | ﹤0.01% | 1762 |
|
|
2024
Q4 | $3.26M | Buy |
148,132
+36,341
| +33% | +$801K | ﹤0.01% | 1816 |
|
|
2024
Q3 | $1.88M | Buy |
111,791
+11,730
| +12% | +$198K | ﹤0.01% | 2066 |
|
|
2024
Q2 | $1.2M | Buy |
100,061
+63,661
| +175% | +$761K | ﹤0.01% | 2282 |
|
|
2024
Q1 | $403K | Hold |
36,400
| – | – | ﹤0.01% | 2342 |
|
|
2023
Q4 | $315K | Hold |
36,400
| – | – | ﹤0.01% | 2415 |
|
|
2023
Q3 | $278K | Hold |
36,400
| – | – | ﹤0.01% | 2452 |
|
|
2023
Q2 | $222K | Hold |
36,400
| – | – | ﹤0.01% | 2550 |
|
|
2023
Q1 | $222K | Hold |
36,400
| – | – | ﹤0.01% | 2550 |
|
|
2022
Q4 | $159K | Hold |
36,400
| – | – | ﹤0.01% | 2469 |
|
|
2022
Q3 | $143K | Hold |
36,400
| – | – | ﹤0.01% | 2649 |
|
|
2022
Q2 | $186K | Hold |
36,400
| – | – | ﹤0.01% | 2591 |
|
|
2022
Q1 | $233K | Buy |
36,400
+5,400
| +17% | +$34.6K | ﹤0.01% | 2648 |
|
|
2021
Q4 | $249K | Buy |
+31,000
| New | +$249K | ﹤0.01% | 2723 |
|